|
Jaguar Health, Inc. (JAGX) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Jaguar Health, Inc. (JAGX) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de Jaguar Health, Inc. (JAGX)! Explore datos financieros auténticos, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estos cambios afectan el valor intrínseco de Jaguar Health, Inc. (JAGX).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.8 | 9.4 | 4.3 | 12.0 | 9.8 | 12.0 | 14.7 | 18.0 | 22.0 | 27.0 |
| Revenue Growth, % | 0 | 62.5 | -53.81 | 175.8 | -18.36 | 22.58 | 22.58 | 22.58 | 22.58 | 22.58 |
| EBITDA | -30.9 | -28.7 | -42.4 | -33.4 | -33.1 | -12.0 | -14.7 | -18.0 | -22.0 | -27.0 |
| EBITDA, % | -534.53 | -306.2 | -976.98 | -279.19 | -339.42 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.9 | 2.3 | 1.8 | 2.3 | 1.2 | 3.1 | 3.8 | 4.7 | 5.8 | 7.1 |
| Depreciation, % | 33.39 | 24.29 | 42.15 | 19.17 | 11.88 | 26.18 | 26.18 | 26.18 | 26.18 | 26.18 |
| EBIT | -32.8 | -31.0 | -44.2 | -35.7 | -34.3 | -12.0 | -14.7 | -18.0 | -22.0 | -27.0 |
| EBIT, % | -567.92 | -330.5 | -1019.12 | -298.36 | -351.31 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 3.5 | 8.1 | 17.1 | 5.5 | 6.5 | 8.6 | 10.5 | 12.9 | 15.8 | 19.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.7 | 4.6 | 2.1 | 2.5 | 2.0 | 4.0 | 4.9 | 6.0 | 7.4 | 9.1 |
| Account Receivables, % | 29.3 | 48.59 | 49.46 | 20.63 | 20.15 | 33.63 | 33.63 | 33.63 | 33.63 | 33.63 |
| Inventories | 2.1 | 2.8 | 4.9 | 7.0 | 9.2 | 7.6 | 9.4 | 11.5 | 14.1 | 17.3 |
| Inventories, % | 36.86 | 29.64 | 113.03 | 58.75 | 94.14 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 |
| Accounts Payable | 5.4 | 4.8 | 4.9 | 5.8 | 5.0 | 8.2 | 10.1 | 12.3 | 15.1 | 18.5 |
| Accounts Payable, % | 92.67 | 50.71 | 113.7 | 48.58 | 50.96 | 68.58 | 68.58 | 68.58 | 68.58 | 68.58 |
| Capital Expenditure | .0 | .0 | .0 | -1.7 | .0 | -.3 | -.4 | -.5 | -.6 | -.8 |
| Capital Expenditure, % | 0 | -0.07458711 | -0.13841 | -14.01 | 0 | -2.84 | -2.84 | -2.84 | -2.84 | -2.84 |
| Tax Rate, % | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 |
| EBITAT | -32.8 | -33.8 | -50.6 | -35.0 | -33.8 | -11.9 | -14.6 | -17.9 | -21.9 | -26.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.3 | -35.6 | -48.3 | -35.9 | -35.1 | -6.4 | -11.9 | -14.6 | -17.9 | -22.0 |
| WACC, % | 17.11 | 17.11 | 17.11 | 16.78 | 16.87 | 17 | 17 | 17 | 17 | 17 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -42.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -22 | |||||||||
| Terminal Value | -149 | |||||||||
| Present Terminal Value | -68 | |||||||||
| Enterprise Value | -111 | |||||||||
| Net Debt | 31 | |||||||||
| Equity Value | -142 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | -368.43 |
What You Will Get
- Real Jaguar Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Jaguar Health, Inc. (JAGX).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis needs.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Jaguar Health's fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections specific to Jaguar Health, Inc. (JAGX).
- Time-Saving and Accurate: Avoid building models from the ground up while ensuring precision and adaptability.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Jaguar Health, Inc. (JAGX).
- WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Jaguar Health, Inc. (JAGX).
- Interactive Dashboard and Charts: Visual representations of key valuation metrics for streamlined analysis.
How It Works
- Download: Get the pre-built Excel file containing Jaguar Health, Inc.'s (JAGX) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and instantly compare results.
- Make Decisions: Leverage the valuation insights to inform your investment strategy.
Why Choose This Calculator for Jaguar Health, Inc. (JAGX)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Jaguar Health’s historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for investment analysis in the healthcare sector.
- Corporate Finance Teams: Evaluate financial scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Offer clients precise valuation insights for Jaguar Health, Inc. (JAGX) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling within healthcare.
- Health Tech Enthusiasts: Gain insights into how companies like Jaguar Health, Inc. (JAGX) are valued in the evolving healthcare market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Jaguar Health, Inc. (JAGX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Jaguar Health, Inc. (JAGX).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.